Stefano Bianchi
Overview
Explore the profile of Stefano Bianchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
309
Citations
1941
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cespon-Fernandez M, Della Rocca D, Magnocavallo M, Betancur A, Lombardo I, Pannone L, et al.
J Interv Card Electrophysiol
. 2025 Mar;
PMID: 40038209
Background: Patients undergoing atrial fibrillation (AF) catheter ablation may require redo procedures involving pulmonary vein (PV) re-isolation and/or ablation of extra-PV sites. Pulsed field ablation (PFA) offers a highly selective...
2.
Sonaglioni A, Casieri F, Nicolosi G, Bianchi S, Lombardo M
J Clin Med
. 2025 Feb;
14(4).
PMID: 40004801
: No previous study has provided a comprehensive evaluation of all biventricular and biatrial myocardial strain parameters in women with previous gestational diabetes mellitus (pGDM). Accordingly, we aimed at investigating...
3.
Frustaci A, Magnocavallo M, Rossi P, Bianchi S, Guarracini S, Di Mauro M, et al.
JACC Clin Electrophysiol
. 2025 Feb;
PMID: 39945712
No abstract available.
4.
Mantovan R, Bianchi S, Pelargonio G, Solimene F, Malacrida M, Carbone A, et al.
J Cardiovasc Electrophysiol
. 2025 Jan;
PMID: 39888109
Background: Recent advancements in ultra-high-density mapping (UHDM) featuring automated functionalities have enhanced our understanding of micro-reentrant atrial tachycardias (mAT) circuits and the precise localization of the origin. Purpose: To evaluate...
5.
Nakasone K, Della Rocca D, Magnocavallo M, Betancur A, Vetta G, Pannone L, et al.
Heart Rhythm
. 2025 Jan;
PMID: 39864479
Background: Catheter ablation is an effective treatment of atrial fibrillation. Pulsed field ablation (PFA) has emerged as a novel energy modality that relies on high-voltage electric fields to achieve cardiac...
6.
Sonaglioni A, Bruno A, Nicolosi G, Bianchi S, Lombardo M, Muti P
Children (Basel)
. 2025 Jan;
11(12.
PMID: 39767880
Background: Gestational diabetes mellitus (GDM) is the most common complication in pregnancy, representing a serious risk for the mother and fetus. Identifying new biomarkers to ameliorate the screening and improving...
7.
Potpara T, Grygier M, Haeusler K, Nielsen-Kudsk J, Berti S, Genovesi S, et al.
Thromb Haemost
. 2024 Dec;
PMID: 39657795
Many patients with atrial fibrillation (AF) who are in need of stroke prevention are not treated with oral anticoagulation or discontinue treatment shortly after its initiation. Despite the availability of...
8.
Vetta G, Della Rocca D, Parlavecchio A, Magnocavallo M, Sorgente A, Pannone L, et al.
Europace
. 2024 Nov;
26(12).
PMID: 39579376
Aims: Pulsed field ablation (PFA) is an innovative technology recently adopted for the treatment of atrial fibrillation (AF). Preclinical and clinical studies have reported a remarkable safety profile, as a...
9.
Scacciavillani R, Della Rocca D, Nair D, Magnocavallo M, Glowniak A, Mohanty S, et al.
JACC Clin Electrophysiol
. 2024 Nov;
11(1):98-106.
PMID: 39570269
Background: Pulsed-field ablation (PFA) is a novel ablation energy source, which leads to selective and irreversible electroporation of cardiomyocytes with no collateral damage to adjacent tissues. The presence of mechanical...
10.
Cancarini G, Santarelli S, Vizzardi V, Amici G, Alberghini E, Russo R, et al.
G Ital Nefrol
. 2024 Nov;
41(5).
PMID: 39508701
No abstract available.